Lactobacillus salivarius UCC118: Triglyceride & Health Markers
A user asks if Lactobacillus salivarius UCC118 lowers triglyceride levels. The assistant finds no evidence for triglycerides but details strong evidence for improved insulin sensitivity, reduced inflammation, and reduced gestational diabetes risk, based on Pillser's research database.
Does Lactobacillus salivarius UCC118 help lower triglyceride levels, and is there any evidence it works for other health markers?
Lactobacillus salivarius UCC118 & Triglycerides
Based on Pillser's research database, there is no published research specifically linking Lactobacillus salivarius UCC118 to reduced triglyceride levels. Neither the strain-specific search nor the broader species-level search returned studies on triglyceride outcomes12.
Evidence for Other Health Markers
However, this probiotic strain has been studied for several other health outcomes. Here's a summary from Pillser's database:
Health Outcome Evidence Strength Effect Size Studies Improved Insulin Sensitivity High Moderate 6 studies, all beneficial3 Reduced Inflammation Moderate Moderate 8 studies, all beneficial (notably reduced CRP in women with gestational diabetes)4 Reduced Prevalence of Gestational Diabetes Moderate Moderate 4 studies, all beneficial (up to 48% lower risk)5 Improved Glucose Metabolism Low Moderate 4 studies, all beneficial (improvements in fasting glucose, insulin, and insulin resistance)6 Improved Gastrointestinal Health Low Small 10 studies, all beneficial7 Reduced Insulin Levels Low Moderate 3 studies (2 beneficial, 1 neutral)8 Reduced Risk of Infection Low Moderate 3 studies, all beneficial9 Improved Gut Health Very Low Small 6 studies, all beneficial10 Improved Immune Function Very Low Small 5 studies, all beneficial11 Key Takeaways
- Triglycerides: No evidence found in Pillser's database for this strain and triglyceride reduction.
- Strongest evidence: This strain has the most robust support for improving insulin sensitivity (high evidence, 6 studies) and reducing inflammation (moderate evidence, 8 studies), especially in populations with metabolic conditions or during pregnancy.
- Gestational diabetes: Multiple meta-analyses show a significant risk reduction of up to 48% with probiotics containing this strain.
If you're interested in supplements containing this strain, would you like me to search for products available on Pillser?
Footnotes
-
Pillser research database, Lactobacillus salivarius UCC118. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Reduced Triglycerides. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Improved Insulin Sensitivity. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Reduced Inflammation. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Reduced Prevalence of Gestational Diabetes Mellitus. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Improved Glucose Metabolism. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Improved Gastrointestinal Health. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Reduced Insulin Levels. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Reduced Risk of Infection. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Improved Gut Health. ↩
-
Pillser research database, Lactobacillus salivarius UCC118 & Improved Immune Function. ↩